The
global breast imaging market is expected to reach USD 7.3 billion
by 2024, according to a new report by Grand View Research, Inc. Increasing
prevalence of breast cancer and supportive government initiatives to increase
awareness are expected to boost demand in the market.
Supportive government initiatives such UK
government campaign’s “Be clear on cancer,” which helped in spreading awareness
about the risk factors, preventive measures, and early diagnosis of cancer.
This campaign also included free screening programs, which helped in diagnosing
around 15,000 cancer patients.
Technological advancements in the imaging
sector are expected to boost growth in the market. Companies such as Gamma
Medica, Dilon Technologies, and SonoCine are completely dedicated to developing
improved technologies in the field of breast imaging. The innovation of
complimentary products such as the breast pad designed by GE Healthcare to
provide comfort to a woman undergoing screening is expected to catalyze the
market growth further.
Full Research Report On Breast Imaging Market Analysis:www.grandviewresearch.com/industry-analysis/breast-imaging-equipment-market
Further
key findings from the report suggest:
·
The 3D tomosynthesis segment is identified
as the fastest growing segment. This technology offers enhanced efficiency and
higher diagnostic accuracy in comparison to other available technologies, which
is expected to aid market growth.
·
North America is likely to dominate
throughout the forecast period with a revenue share of over 30.0% by
2024.Government initiatives including the precision medicine initiative,
promotes the development of personalized medicine, which is anticipated to
foster market growth.
·
Asia Pacific is anticipated to grow at the
fastest rate of12.0% over the forecast period. The increasing number of
investments in the healthcare sector coupled with the rising awareness of
breast cancer and other associated conditions is anticipated to propel the
market growth in this region.
·
Some major players of the market are
Siemens Healthcare, GE Healthcare, Dilon Technologies, Inc., Hologic, Inc.,
Gamma Medica, Inc., Fujifilm Holdings Corporation, SonoCine, Inc., Philips
Healthcare, Toshiba Corporation, and Aurora Imaging Technology, Inc.
Browse More Reports Of This Category By Grand View Research At: www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the global breast
imaging market on the basis of technology and region:
Breast Imaging Technology Outlook (Revenue,
USD Million; 2013 - 2024)
·
Ionizing
o
Full-Field Digital Mammography
o
Analog Mammography
o
Positron Emission Mammography
o
Electric Impedance Tomography
o
Cone-Beam Computed Tomography
o
Positron Emission Tomography & Computed
Tomography
o
3D Breast Tomosynthesis
o
MBI/BSGI
·
Non Ionizing
o
MRI
o
Thermography
o
Ultrasound
o
Optical Imaging
o
Automated Whole-Breast Ultrasound
Breast Imaging Regional Outlook (Revenue,
USD Million; 2013 - 2024)
·
North America
·
Europe
·
Asia Pacific
·
Latin America
·
Middle East & Africa
Access
Full Press Release of this Report:
www.grandviewresearch.com/press-release/global-breast-imaging-equipment
www.grandviewresearch.com/press-release/global-breast-imaging-equipment
About Grand View Research
Grand View Research, Inc. is a U.S. based market research
and consulting company, registered in the State of California and headquartered
in San Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed
business decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
For
more information: www.grandviewresearch.com
